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Virus Protein # copies/
Virion
Interactions with 
Other Viral Factors
Virus Protein Function cellular Partners cellular Partner Functions; Results of 
Interaction with Viral Proteins
Matrix, MA (p17Gag) ~5000 Transmembrane 
glycoprotein (TM)
Plasma membrane targeting 
of Gag for virion assembly; 
Env incorporation; post-entry 
events
Phosphatidylinositol (PI) 4,5-bisphosphate 
[PI(4,5)P2]
Mediates Gag interaction with plasma membrane 
TIP47 Promotes Env incorporation into virions
Capsid, CA (p24Gag) ~5000 (see 
Briggs et 
al., 2004)
Virion core structure and 
assembly
Cyclophilin A Modulates sensitivity to TRIM5α; suppressed by 
cyclosporin A
TRIM5α Post-entry inhibitor of infection
Nucleocapsid, NC 
(p7Gag) 
~5000 RNA genome (gRNA) 
of virus
Virion packaging of genome 
RNA; RNA chaperone; virion 
assembly
HP68/ABCE1 Promotes virion assembly
APOBEC3G, APOBEC3F Packaged into virions with RNA; inhibits 
infection; G-to-A hypermutation 
tRNALys3 Primer for reverse transcription
7SL RNA, other cellular RNAs Unknown
p6Gag ~5000 Vpr Promotes virion budding TSG101 Recruit ESCRT machinery to promote virion 
budding
ALIX
Protease, PR ~250 Gag, Pol Proteolytic processing of Gag 
and Gag-Pol polyproteins
PR may cleave many cellular proteins
Reverse 
Transcriptase, RT
~250 gRNA, IN cDNA synthesis; RNaseH 
domain degrades RNA
tRNALys3 Primer for reverse transcription
Integrase, IN ~250 Viral cDNA, RT Covalent insertion of virus 
cDNA into cellular DNA
LEDGF/p75 cDNA integration; targeting to active genes
INI1 Virion assembly; reverse transcription/integration
UNG2 DNA repair enzyme; enhances replication fi delity
Surface 
Glycoprotein, SU 
(gp120Env) 
4 to 35 
trimers
TM Binds cell-surface receptors; 
mediates virus attachment 
and entry 
CD4 CD4 plus CCR5/CXCR4 mediate virion entry; 
major determinants of viral tropism
Chemokine receptors (CCR5 and CXCR4)
C-type lectin receptors (DC-SIGN, Langerin) Virion capture; viral transmission from dendritic 
cells to T cells
Transmembrane 
Glycoprotein, TM 
(gp41Env) 
4 to 35 
trimers
SU, MA Contains fusion peptide; 
mediates membrane fusion 
and virus entry
TIP47 Env incorporation into virions
Clathrin sorting machinery (AP-1, AP-2) Env downregulation from cell surface
Virion Infectivity 
Factor, Vif
1 to 150 Suppresses APOBEC3G/ 
APOBEC3F, host factors that 
inhibit infection
APOBEC3G, APOBEC3F Vif recruits Cullin5-ElonginB/C-Rbx E3 ubiquitin 
ligase to APOBEC3G, APOBEC3F; degradation 
of APOBEC3G and APOBEC3FElonginC, Cullin5
Viral Protein R, Vpr ~700 p6 Moderate enhancer of post-
entry infectivity; G2/M cell-
cycle arrest
DCAF1/VprBP Bridges Vpr and unknown substrates to 
Cullin4A-DDB1-Rbx E3 ubiquitin ligase
nucleoporins (various) Post-entry nuclear import
UNG2 DNA repair enzyme; enhances replication fi delity
CDC25C G2 cell-cycle arrest
trans-Activator of 
Transcription, Tat
No Viral RNA via trans-
acting response (TAR) 
element
Potent activator of viral 
transcription elongation
Cyclin T1 Cyclin T with CDK9 forms p-TEFb, which 
promotes viral transcription
Importin-β/Karyopherin-β1 Nuclear import receptor
Regulator of 
Expression of Virion 
Proteins, Rev
No Intron-containing viral 
RNAs via Rev response 
element (RRE)
Induces nuclear export of 
intron-containing viral RNAs
CRM1/Exportin-1 Nuclear export receptor; transport of Rev and 
intron-containing viral RNAs to cytoplasm
Importin-β/Karyopherin-β1 Nuclear import receptor
Viral Protein U, Vpu No CD4/MHC downregulation; 
induces virion release from 
host cell surface
CD4 Vpu recruits Cullin1-SCFTrCP E3 ubiquitin ligase to 
CD4 resulting in CD4 degradationβTrCP
Tetherin/BST-2/CD317 Blocks virion release from host cell surface
Negative Factor, 
Nef
Yes, 
cleaved 
by PR
CD4/MHC downregulation; 
T-cell activation; moderate 
enhancer of viral infectivity; 
blocks apoptosis; 
pathogenicity determinant
CD4, CD28, MHC-I, MHC-II, TCR-CD3ζ, 
other cell-surface proteins
Nef connects immunologically important host 
surface proteins to clathrin-dependent and 
-independent sorting pathways to regulate 
traffi cking, degradation, and immune recognitionAP-1, AP-2, AP-3, β-COP, vacuolar ATPase, 
PACS-SRC family kinase-PI3K complex
Several kinases, including PAK2, LCK, ASK1 Roles in signal transduction, host cell activation, 
blocking apoptosis, stimulating viral replication
Dynamin-2 Enhances virion infectivity
MA, CA, NC, p6 synthesized as the p55Gag polyprotein (Gag, group-specifi c antigen), which is cleaved 
by viral PR after particle assembly and during maturation to yield these four proteins and the p1 and p2 
spacer peptides. PR, RT, and IN synthesized as a 160 kDa Gag-Pol polyprotein (Pol, polymerase), which 
is cleaved by PR to yield these three enzymes including the 51 kDa and 66 kDa subunits of the RT dimer 
(as well as Gag proteins).
Synthesis of the 160 kDa envelope (Env) glycoprotein precursor is followed by removal of signal peptide 
in the ER, extensive posttranslational modifi cation and cleavage by a furin-like protease into SU and TM, 
which are further assembled into Env trimers.
TRIM5α variants in the natural host species for different HIV and SIV strains are inactive against those 
“cognate” viruses. For example, human TRIM5α blocks infection by SIVagm from African green mon-
keys but not HIV-1; African green monkey TRIM5α blocks infection by HIV-1 but not SIVagm.
APOBEC3G/F of the natural hosts of HIV and SIV strains are inhibited by the Vifs of those viruses to pre-
serve viral infectivity. For example, human APOBEC3G is inhibited by HIV-1 Vif but not by SIVagm Vif.
Most Nefs of SIVs and HIV-2 downregulate TCR-CD3, which correlates with reduced viral pathogenicity 
in natural hosts; HIV-1 Nef does not downregulate human TCR-CD3.
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Table: HIV Proteins and Their Cellular Partners
Human immunodeficiency virus type-1 (HIV-1) is the etiologic agent of acquired immunodeficiency syndrome (AIDS) and the prototypic member of the lentivirus genus of 
retroviruses. Lentivirus infections are considered as chronic or “slow” and, when pathogenic (most notably, HIV-1 infection of humans), are associated with severe immuno-
logical and neurological dysfunction. HIV-1 has nine genes, with only the gag, pol, and env genes common to all replication-competent retroviruses. The pol gene encodes 
two enzymes that define the replicative strategy of the retrovirus: reverse transcriptase (RT) copies the viral RNA genome into DNA, and integrase (IN) mediates the insertion 
of that DNA into the genomic DNA of an infected cell to establish the provirus (and persistent infection). A third enzyme protease (PR), also derived from pol, is necessary 
for maturation of virions into an infectious form. Of the remaining six regulatory/accessory genes of HIV-1, tat and rev are essential for virus replication, whereas vif, vpr, 
vpu, and nef are thought to modulate immune functions in vivo (often in a species-specific fashion). Current frontline highly active antiretroviral therapy (HAART) for treating 
AIDS includes combinations of small-molecule inhibitors of PR and RT (nucleoside RT inhibitors, NRTIs; non-nucleoside RT inhibitors, NNRTIs). A peptide inhibitor of TM 
that inhibits viral entry is used in salvage therapy, and a small-molecule IN inhibitor, Raltegravir, was recently approved by the FDA. Three crucial viral enzymes are inhibited 
pharmacologically, but blocking remaining viral proteins and virus-host interactions is an important objective (a CCR5 coreceptor antagonist, Maraviroc, received FDA ap-
proval in 2007).
Figure: Genetic Organization of HIV-1
The ~9.7 kb provirus comprises two LTRs (long terminal repeats) flanking the internal unique sequence. The 5′ LTR is a promoter for transcription; the 3′ LTR ensures poly-
adenylation. Regions encoding Gag, Pol, and Env proteins (dark gray); regions encoding regulatory/accessory proteins Tat, Rev, Vif, Vpr, Vpu, and Nef (various colors); Gag, 
Pol, and Env precursor proteins (green/blue; origins of mature protein derivatives and sites of proteolytic cleavage are shown). PBS (primer-binding site for tRNALys3) enables 
initiation of reverse transcription; ψ, RNA packaging sequence for virion encapsidation of viral genome RNA; Tat binds to TAR to stimulate viral transcription; Rev binds to 
RRE to activate nuclear export of unspliced viral RNAs.
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